CRISPR Therapeutics AG (CRSP) Treasury Shares (2015 - 2026)

CRISPR Therapeutics AG has disclosed Treasury Shares across 9 years of filings, most recently posting $60000.0 for Q2 2026.

• In Q2 2026, Treasury Shares fell 3.23% year-over-year to $60000.0; the TTM figure through Jun 2026 stood at $60000.0 (down 3.23% YoY), while the FY2025 annual figure was $60000.0, down 3.23% from the prior year.
• Treasury Shares came in at $60000.0 for Q2 2026 at CRISPR Therapeutics AG, roughly flat from $60000.0 in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $21.0 million in Q2 2023 to a low of $115316.0 in Q4 2025.
• Average Treasury Shares over 5 years is $11.1 million, with a median of $17.7 million recorded in 2026.
• Year-over-year, Treasury Shares changed 0.0% in 2022 and fell 3.23% in 2025.
• Over 5 years, Treasury Shares stood at $63000.0 in 2022, then retreated by 1.59% to $62000.0 in 2023, then changed by 0.0% to $62000.0 in 2024, then decreased by 3.23% to $60000.0 in 2025, then changed by 0.0% to $60000.0 in 2026.
• Per Business Quant data, the three most recent Treasury Shares figures were $60000.0 in Q2 2026, $60000.0 in Q1 2026, and $60000.0 in Q4 2025.